News - Plexus Ventures

Plexus Ventures Assists Glenmark Pharmaceuticals to Out-License Ryaltris™ Nasal Spray to Menarini for numerous markets throughout Europe

Jan 11, 2021

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...

Plexus Ventures Appoints Ramon Brusco as Director for Spain, Portugal and MENA

Jun 1, 2020

Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Ramon Brusco, based in Barcelona, as Director for Spain and Portugal. Ramon has more than 20 years’ experience with pharmaceutical firms and M&A boutiques focused on Life Sciences. He brings...

Plexus Ventures Assists Glenmark Pharmaceuticals to Divest a CNS Product Portfolio and Commercial Team in Poland to Neuraxpharm

Apr 7, 2020

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the completion of a divestiture project on behalf of its client, Glenmark Pharmaceuticals Ltd. Plexus Ventures advised Glenmark on the sale of a CNS product portfolio and sales team to Neuraxpharm....

Olessia Kamp Joins Plexus Ventures as Senior Advisor in Germany

Mar 1, 2020

Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...

Dr. Daniel Sieiro Mosti Joins Plexus Ventures as Scientific Associate for Gene and Cell Therapies

Sep 1, 2019

Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...

Plexus Ventures advises Cinfa Group in PLG’s “Deal of the Year”

Mar 26, 2019

London, England – The Pharmaceutical Licensing Group, whose mission is promote and support excellence in deal making across the healthcare industry, recently awarded Mundipharma International its inaugural “PLG Deal of the Year” for its acquisition of Cinfa Biotech....